CurrentEndo coverage · page 5 of 5
The Lancet Diabetes & Endocrinology
Latest from The Lancet Diabetes & Endocrinology
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward
Research articleT2D & other
Lancet Diabetes Endocrinol
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)
Cross-sectional studyT2D & other
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study
Cohort studyDiabetes in pregnancy
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study
Cohort studyLipids & liver
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
Randomized controlled trialT2D & other
Lancet Diabetes Endocrinol
Lancet Diabetes Endocrinol
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Guideline or statementTechnology